Citadel Advisors’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$770K Buy
64,700
+12,100
+23% +$124K ﹤0.01% 8288
2025
Q4
$524K Sell
52,600
-124,900
-70% -$1.19M ﹤0.01% 8921
2025
Q3
$1.59M Sell
177,500
-77,700
-30% -$720K ﹤0.01% 6541
2025
Q2
$2.41M Sell
255,200
-107,500
-30% -$948K ﹤0.01% 5373
2025
Q1
$3.93M Buy
362,700
+79,000
+28% +$795K ﹤0.01% 4286
2024
Q4
$2.7M Buy
283,700
+83,800
+42% +$848K ﹤0.01% 5019
2024
Q3
$2.24M Buy
199,900
+167,900
+525% +$1.78M ﹤0.01% 5313
2024
Q2
$320K Buy
32,000
+27,600
+627% +$280K ﹤0.01% 9007
2024
Q1
$50.6K Sell
4,400
-10,900
-71% -$92.6K ﹤0.01% 12163
2023
Q4
$112K Sell
15,300
-3,800
-20% -$30K ﹤0.01% 10792
2023
Q3
$174K Sell
19,100
-17,700
-48% -$212K ﹤0.01% 10137
2023
Q2
$448K Buy
36,800
+8,200
+29% +$91.4K ﹤0.01% 8185
2023
Q1
$355K Buy
28,600
+26,000
+1,000% +$478K ﹤0.01% 9013
2022
Q4
$50K Sell
2,600
-26,100
-91% -$552K ﹤0.01% 12141
2022
Q3
$539K Buy
+28,700
New +$590K ﹤0.01% 8300
2022
Q1
Sell
-13,500
Closed -$330K 13478
2021
Q4
$330K Sell
13,500
-8,400
-38% -$197K ﹤0.01% 10716
2021
Q3
$510K Buy
21,900
+3,300
+18% +$79.8K ﹤0.01% 9812
2021
Q2
$510K Buy
18,600
+1,000
+6% +$28.5K ﹤0.01% 10015
2021
Q1
$647K Buy
17,600
+11,400
+184% +$403K ﹤0.01% 9121
2020
Q4
$233K Buy
+6,200
New +$192K ﹤0.01% 9502

Other funds holding AHCO

Citadel Advisors's AHCO Position: Q1 2026 in Review

Citadel Advisors increased its AdaptHealth (AHCO) stake by 72% in Q1 2026, buying an estimated $553K and bringing the position to 129,106 shares worth $1.54M. The position accounts for ﹤0.01% of the portfolio, ranked #6656.

Citadel Advisors first reported a position in AHCO in Q1 2020 and has held it in 22 quarters since. The position peaked at $13.9M in Q1 2023. 241 funds tracked by Wall St. Rank hold AHCO as of Q1 2026.

  • Citadel Advisors held 129,106 shares of AdaptHealth worth $1.54M as of Q1 2026.
  • Citadel Advisors bought 54,056 AdaptHealth shares in Q1 2026, an estimated $553K.
  • AdaptHealth made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #6656 holding.
  • Citadel Advisors first reported a position in AdaptHealth in Q1 2020 and has held it in 22 quarters since.
  • Citadel Advisors's AdaptHealth position peaked at $13.9M in Q1 2023.
  • 241 funds tracked by Wall St. Rank held AdaptHealth as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.